(b)(4).Communication/interviews - from further questioning it was indicated that the device was not pre-soaked in saline or any other medium prior to use as recommended in ifu cautions.A 5-year review of previous similar events for gelweave graft gave an occurrence rate of (b)(4) (complaints v sales).A review of qc and manufacturing records showed that the batch was manufactured to design specification.All testing including physical test of base material met all acceptance criteria - all pre-release leakage testing was well within product acceptance criteria.No additional reports of leakage were received for any other devices in this batch.Vascutek now considers this complaint closed.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.
|
Patient admitted for acute type a dissection debakey type i based on a pre-existing ascending aneurysm, no anticoagulation treatment in medical history, emergent arch replacement.Patient underwent aortic arch replacement under hypothermic circulatory arrest (25 °c) and bilateral antegrade cerebral perfusion.After weaning from cardiopulmonary bypass and adequate substitution of protamine, progressive leakage of prosthesis in the area of first side branch of plexus prosthesis and along black suture mark of main body.Clinical relevant blood loss, despite massive substitution of fibrinogen, thrombocytes, protamine, desmopressin and fresh frozen plasma no improvement of leakage over three hours.Additional local fibrin glue and other hemostyptic material applied on top of prosthetic material.After wound closure no relevant bleeding, patient is extubated and clinical stable.Patient received massive substitution of blood and coagulation products but tolerated all very well.Operative time was prolonged but patient recovered uneventful.
|